Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAA Closure vs Antithrombotic Therapy in AF Patients with DES
NCT02606552Phase 4Terminated
- Sponsor
- Yonsei University
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) and coronary artery disease (CAD) (3 arms), sponsored by Yonsei University. Primary endpoints: Major adverse cardiac and cerebrovascular events at 5 years and GUSTO bleeding at 5 years. Started Jul 2016; status: terminated.
02
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02606552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02606552.